Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Oric Pharmaceuticals Inc (ORIC)

Oric Pharmaceuticals Inc (ORIC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Oric Pharmaceuticals Inc 240 E. GRAND AVE. 2ND FLOOR SOUTH SAN FRANCISCO CA 94080 USA

www.oricpharma.com P: 650-388-5600

Description:

ORIC Pharmaceuticals Inc. is a clinical stage oncology company. It is focused on developing treatments which address mechanisms of therapeutic resistance. The company's product candidate consists of ORIC-101 and ORIC-533 which are in clinical stage. ORIC Pharmaceuticals Inc. is based in San Francisco, United States.

Key Statistics

Overview:

Market Capitalization, $K 647,925
Enterprise Value, $K 624,545
Shares Outstanding, K 67,422
Annual Sales, $ 0 K
Annual Net Income, $ -100,700 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -28,330 K
EBIT, $ -110,780 K
EBITDA, $ -115,920 K
60-Month Beta 1.19
% of Insider Shareholders 5.55%
% of Institutional Shareholders 95.05%
Float, K 63,680
% Float 94.45%
Short Volume Ratio 0.87

Growth:

1-Year Return 83.91%
3-Year Return -62.08%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.49 on 03/11/24
Latest Earnings Date 05/13/24 [--]
Earnings Per Share ttm -1.96
EPS Growth vs. Prev Qtr -11.36%
EPS Growth vs. Prev Year 5.77%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

ORIC Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -41.24%
Return-on-Assets % -37.31%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 2.92
Book Value/Share 3.33
Interest Coverage -2.93
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar